Medtronic Appoints New Director Robert L. Lerman

Ticker: MDT · Form: 8-K · Filed: 2024-06-26T00:00:00.000Z

Sentiment: neutral

Topics: board-appointment, governance, personnel

Related Tickers: MDT

TL;DR

Medtronic adds MIT prof/ex-Labor Dept economist Robert Lerman to its board.

AI Summary

On June 21, 2024, Medtronic plc announced the appointment of Robert L. Lerman as a new independent director to its Board of Directors, effective immediately. Lerman brings extensive experience in compensation and human capital management, having previously served as Chief Economist for the U.S. Department of Labor and as a professor at MIT. His appointment is part of the company's ongoing efforts to strengthen its board's expertise.

Why It Matters

The addition of a director with expertise in compensation and human capital management could influence future executive pay structures and talent strategies at Medtronic.

Risk Assessment

Risk Level: low — The appointment of a new director is a routine corporate governance event with no immediate financial implications.

Key Players & Entities

FAQ

When was Robert L. Lerman appointed to Medtronic's Board of Directors?

Robert L. Lerman was appointed to Medtronic's Board of Directors effective June 21, 2024.

What is Robert L. Lerman's primary area of expertise?

Robert L. Lerman's primary area of expertise is compensation and human capital management.

What previous roles has Robert L. Lerman held?

Robert L. Lerman previously served as Chief Economist for the U.S. Department of Labor and as a professor at MIT.

What is Medtronic's standard industrial classification?

Medtronic's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].

What is Medtronic's fiscal year end?

Medtronic's fiscal year end is April 26.

From the Filing

0001613103-24-000076.txt : 20240626 0001613103-24-000076.hdr.sgml : 20240626 20240626090125 ACCESSION NUMBER: 0001613103-24-000076 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240621 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241070827 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20240621.htm 8-K mdt-20240621 0001613103 Medtronic plc D02 XH02 false 0001613103 2024-06-21 2024-06-21 0001613103 us-gaap:CommonStockMember 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due2025Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2025Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2025Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due2027Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2028Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2028Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2031Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2032Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2034Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2040Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due2049Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2050Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2043Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2020Due2049Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotes2019Due2050Member 2024-06-21 2024-06-21 0001613103 mdt:SeniorNotesDue2053Member 2024-06-21 2024-06-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 20 On Hatch, Lower Hatch Street Dublin 2 , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written commun

View on Read The Filing